[HTML][HTML] NIR-cyanine dye linker: a promising candidate for isochronic fluorescence imaging in molecular cancer diagnostics and therapy monitoring

D Komljenovic, M Wiessler, W Waldeck, V Ehemann… - Theranostics, 2016 - ncbi.nlm.nih.gov
Personalized anti-cancer medicine is boosted by the recent development of molecular
diagnostics and molecularly targeted drugs requiring rapid and efficient ligation routes …

Drug delivery platform comprising long-wavelength fluorogenic phenolo-cyanine dye for real-time monitoring of drug release

M Bokan, G Gellerman, LD Patsenker - Dyes and Pigments, 2019 - Elsevier
Drug delivery platforms comprising an anticancer drug bound to a fluorogenic dye are of
great importance for theranostics and personalized medicine. The existing platforms suffer …

Non-invasive, real-time reporting drug release in vitro and in vivo

Y Zhang, Q Yin, J Yen, J Li, H Ying, H Wang… - Chemical …, 2015 - pubs.rsc.org
We developed a real-time drug-reporting conjugate (CPT-SS-CyN) composed of a near-
infrared (NIR) fluorescent cyanine-amine dye (CyN), a disulfide linker, and a model …

Receptor-avid exogenous optical contrast and therapeutic agents

SI Achilefu, R Rajagopalan, RB Dorshow… - US Patent …, 2004 - Google Patents
Cyanine dye bioconjugates useful for diagnostic imaging and therapy are disclosed. The
conjugates include Several cyanine dyes with a variety of bis-and tetrakis (carboxylic acid) …

Doubly Strapped Zwitterionic NIR‐I and NIR‐II Heptamethine Cyanine Dyes for Bioconjugation and Fluorescence Imaging

DH Li, RS Gamage, AG Oliver, NL Patel… - Angewandte …, 2023 - Wiley Online Library
Heptamethine cyanine dyes enable deep tissue fluorescence imaging in the near infrared
(NIR) window. Small molecule conjugates of the benchmark dye ZW800‐1 have been tested …

Receptor-avid exogenous optical contrast and therapeutic agents

S Achilefu, R Rajagopalan, RB Dorshow… - US Patent …, 2010 - Google Patents
Cyanine dye bioconjugates useful for diagnostic imaging and therapy are disclosed. The
conjugates include several cyanine dyes with a variety of bis-and tetrakis (carboxylic acid) …

Tumor-targeted optical contrast agents

SI Achilefu, R Rajagopalan, RB Dorshow… - US Patent …, 2007 - Google Patents
Cyanine dye bioconjugates useful for diagnostic imaging and therapy are disclosed. The
conjugates include several cyanine dyes with a variety of bis-and tetrakis (carboxylic acid) …

Receptor-avid exogenous optical contrast and therapeutic agents

SI Achilefu, R Rajagopalan, RB Dorshow… - US Patent …, 2009 - Google Patents
Cyanine and Indocyanine dye compounds and bioconjugates are disclosed. The present
invention includes several cyanine and indocyanine dyes, including bioconjugates of the …

[HTML][HTML] Improved tumor targeting and longer retention time of NIR fluorescent probes using bioorthogonal chemistry

X Zhang, B Wang, N Zhao, Z Tian, Y Dai, Y Nie… - Theranostics, 2017 - ncbi.nlm.nih.gov
The traditional labeling method for targeted NIR fluorescence probes requires directly
covalent-bonded conjugation of targeting domains and fluorophores in vitro. Although this …

Optical fluorescent imaging

J Kovar, J Chen, DR Draney, DM Olive… - US Patent …, 2009 - Google Patents
12. Will Compounds and methods a disclosed that are useful for 5. 5 69. 587. A 10/1996
Waggoner noninvasive imaging in the near-infrared (NIR) spectral 5. 57 1388 A 1 1/1996 …